IL254580B - Pseudomonas aeruginosa lecb inhibitors - Google Patents
Pseudomonas aeruginosa lecb inhibitorsInfo
- Publication number
- IL254580B IL254580B IL254580A IL25458017A IL254580B IL 254580 B IL254580 B IL 254580B IL 254580 A IL254580 A IL 254580A IL 25458017 A IL25458017 A IL 25458017A IL 254580 B IL254580 B IL 254580B
- Authority
- IL
- Israel
- Prior art keywords
- lecb
- inhibitors
- pseudomonas aeruginosa
- aeruginosa
- pseudomonas
- Prior art date
Links
- 108700027882 Pseudomonas aeruginosa LecB Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15160612 | 2015-03-24 | ||
| PCT/EP2016/056486 WO2016151066A1 (en) | 2015-03-24 | 2016-03-24 | Inhibitors of pseudomonas aeruginosa lecb |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL254580A0 IL254580A0 (en) | 2017-11-30 |
| IL254580B true IL254580B (en) | 2020-11-30 |
Family
ID=52706073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL254580A IL254580B (en) | 2015-03-24 | 2017-09-18 | Pseudomonas aeruginosa lecb inhibitors |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10407398B2 (enExample) |
| EP (1) | EP3274341B1 (enExample) |
| JP (2) | JP6862410B2 (enExample) |
| CN (1) | CN107531686B (enExample) |
| AU (1) | AU2016236187B2 (enExample) |
| IL (1) | IL254580B (enExample) |
| WO (1) | WO2016151066A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7430381B2 (ja) * | 2020-02-04 | 2024-02-13 | 水谷ペイント株式会社 | バイオフィルム破壊能の評価方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT72878B (en) | 1980-04-24 | 1983-03-29 | Merck & Co Inc | Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents |
| US5789385A (en) * | 1993-06-16 | 1998-08-04 | Glycomed Incorporated | Sialyl Lewisx mimetics containing phenyl backbones |
| EP2650289B1 (en) | 2012-04-10 | 2016-07-27 | Universität Konstanz | Glycomimetics as pseudomonas Aeruginosa lectin inhibitors |
-
2016
- 2016-03-24 CN CN201680024047.9A patent/CN107531686B/zh active Active
- 2016-03-24 WO PCT/EP2016/056486 patent/WO2016151066A1/en not_active Ceased
- 2016-03-24 AU AU2016236187A patent/AU2016236187B2/en active Active
- 2016-03-24 EP EP16713807.2A patent/EP3274341B1/en active Active
- 2016-03-24 JP JP2018500857A patent/JP6862410B2/ja active Active
- 2016-03-24 US US15/560,784 patent/US10407398B2/en active Active
-
2017
- 2017-09-18 IL IL254580A patent/IL254580B/en active IP Right Grant
-
2020
- 2020-11-19 JP JP2020192508A patent/JP2021046411A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN107531686B (zh) | 2021-07-09 |
| AU2016236187B2 (en) | 2020-05-21 |
| CN107531686A (zh) | 2018-01-02 |
| WO2016151066A1 (en) | 2016-09-29 |
| CA2980406A1 (en) | 2016-09-29 |
| EP3274341A1 (en) | 2018-01-31 |
| IL254580A0 (en) | 2017-11-30 |
| AU2016236187A1 (en) | 2017-10-12 |
| JP2021046411A (ja) | 2021-03-25 |
| JP2018510908A (ja) | 2018-04-19 |
| US10407398B2 (en) | 2019-09-10 |
| EP3274341B1 (en) | 2022-11-02 |
| JP6862410B2 (ja) | 2021-04-21 |
| US20180155310A1 (en) | 2018-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL321844A (en) | Menin–MLL interaction inhibitors | |
| IL259560A (en) | Inhibitors of the menin-mll interaction | |
| PL3512850T3 (pl) | Inhibitory interakcji menina-mll | |
| IL251584A0 (en) | Dihydropyrrolopyridines ror-gamma inhibitors | |
| EP3102576B8 (en) | Dihydropyrrolopyridine inhibitors of ror-gamma | |
| ZA201604272B (en) | Inhibitors of glutaminase | |
| IL257061A (en) | Inhibitors of ezh2 | |
| IL259796A (en) | Aza-benzimidazole inhibitors of pad4 | |
| GB201521059D0 (en) | Inhibitors of metallo-beta-lactamases | |
| IL265139B (en) | Dopamine-b-hydroxylase inhibitors | |
| GB201708457D0 (en) | Inhibitors of metallo-beta-lactamases | |
| GB201612860D0 (en) | Inhibitors | |
| IL253322A0 (en) | bace1 inhibitors | |
| AU2016205137B2 (en) | Furoquinolinediones as inhibitors of TDP2 | |
| GB201708451D0 (en) | Inhibitors of metallo-beta-lactamases | |
| IL254580B (en) | Pseudomonas aeruginosa lecb inhibitors | |
| AU2015903172A0 (en) | Inhibitors of necroptosis | |
| AU2015900416A0 (en) | Inhibitors of necroptosis | |
| HK1228907A1 (en) | Novel inhibitors of glutaminase | |
| HK1228906A1 (en) | Novel glutaminase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |